11 Early-Phase Trial Designs That Cut Late-Stage Failure…
From integrated Phase I/II/III studies to biomarker-driven endpoints, these design frameworks show how protocol decisions made early determine Phase III ·…
Public posts from October 2026, newest first. Each heading links to the post.
From integrated Phase I/II/III studies to biomarker-driven endpoints, these design frameworks show how protocol decisions made early determine Phase III ·…
New research shows unmodified LLMs produce error rates that create real compliance risks for protocols, ICFs, and CSRs. · When researchers tested GPT-4o on…
Three medical universities, deep specialist expertise and an accelerated regulatory pathway give sponsors a focused environment for high quality European…
How AI-driven document generation is reshaping protocols, ICFs, and CSRs while reducing timelines and compliance risks. · Clinical trial document automation…
New regulatory frameworks clarify validation requirements when AI tools draft protocols, ICFs, and study reports. · Since 2016, FDA has reviewed more than 500…
Protocol amendments, submission delays, and site confusion often trace back to document errors that never appear in the original writing budget. · When your…
Swissmedic predictability, seven nationally coordinated CTUs and the Basel pharma supercluster give sponsors a high credibility environment for complex…
Informed consent deficiencies remain a top FDA inspection finding. Here's what sites get wrong and how to fix it. · Informed consent failures appeared across…
The CDISC standard turns static protocol tables into structured data, cutting amendment rework and EDC build errors. · Roughly 90% of clinical trial protocols…
Dense university hospital networks, strong Phase I capability and a highly developed CRO ecosystem give sponsors a compact base for European trial execution…
What site teams need to know about the structured documents that support every trial and submission. · Clinical regulatory writing produces the structured…